{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:58:42Z","timestamp":1789945122507,"version":"4.0.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["JPND\/0002\/2011"],"award-info":[{"award-number":["JPND\/0002\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["JPND\/0003\/2011"],"award-info":[{"award-number":["JPND\/0003\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["ENMed\/0001\/2013"],"award-info":[{"award-number":["ENMed\/0001\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia"},{"DOI":"10.13039\/501100003381","name":"Minist\u00e9rio da Educa\u00e7\u00e3o e Ci\u00eancia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","award":["PT2020"],"award-info":[{"award-number":["PT2020"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.cca.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T18:07:22Z","timestamp":1452794842000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Emerging molecular biomarker targets for amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"455","author":[{"given":"J\u00falia","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamede","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.01.011_bb0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/01.wnl.0000343008.26874.d1","article-title":"Parals, epidemiology of ALS in Italy: a 10-year prospective population-based study","volume":"72","author":"Chio","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1212\/01.WNL.0000048208.54755.78","article-title":"The epidemiology of ALS in Modena, Italy","volume":"60","author":"Mandrioli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.50.1.66","article-title":"Prognostic indicators of survival in ALS. ALS CNTF treatment study group","volume":"50","author":"Stambler","year":"1998","journal-title":"Neurology"},{"issue":"Suppl","key":"10.1016\/j.cca.2016.01.011_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0022-510X(96)00089-5","article-title":"Motor neuron disease presenting with respiratory failure","volume":"139","author":"de Carvalho","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2016.01.011_bb0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17482960701553956","article-title":"Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity?","volume":"8","author":"Gouveia","year":"2007","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.cca.2016.01.011_bb0030","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2174\/187152710793237502","article-title":"Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis","volume":"9","author":"Costa","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.cca.2016.01.011_bb0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","article-title":"EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2014revised report of an EFNS task force","volume":"19","author":"Andersen","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00415-008-0738-5","article-title":"Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis","volume":"255","author":"Costa","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/mus.24659","article-title":"Quality of life in amyotrophic lateral sclerosis patients and caregivers: impact of assistive communication from early stages","author":"Londral","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2016.01.011_bb0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","article-title":"Biomarkers in amyotrophic lateral sclerosis","volume":"8","author":"Turner","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00702-012-0806-y","article-title":"CSF markers in amyotrophic lateral sclerosis","volume":"119","author":"Tarasiuk","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cca.2016.01.011_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/17482968.2011.627589","article-title":"Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS","volume":"13","author":"Otto","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2016.01.011_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/21678421.2013.778554","article-title":"Mechanisms, models and biomarkers in amyotrophic lateral sclerosis","volume":"14","author":"Turner","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.cca.2016.01.011_bb0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/prca.201200067","article-title":"Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery","volume":"7","author":"Kruger","year":"2013","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.cca.2016.01.011_bb0080","doi-asserted-by":"crossref","first-page":"525097","DOI":"10.1155\/2014\/525097","article-title":"Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?","volume":"2014","author":"Robelin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2016.01.011_bb0085","doi-asserted-by":"crossref","first-page":"17565","DOI":"10.3390\/ijms160817565","article-title":"Brain-specific cytoskeletal damage markers in cerebrospinal fluid: is there a common pattern between amyotrophic lateral sclerosis and primary progressive multiple sclerosis?","volume":"16","author":"Abdelhak","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2016.01.011_bb0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cca.2016.01.011_bb0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.20481","article-title":"Assessment of cortical excitability using threshold tracking techniques","volume":"33","author":"Vucic","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2016.01.011_bb0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nicl.2014.02.011","article-title":"Lessons of ALS imaging: pitfalls and future directions \u2014 a critical review","volume":"4","author":"Bede","year":"2014","journal-title":"Neuroimage Clin."},{"issue":"Pt B","key":"10.1016\/j.cca.2016.01.011_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.expneurol.2014.04.013","article-title":"Dissection of genetic factors associated with amyotrophic lateral sclerosis","volume":"262","author":"Leblond","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrneurol.2014.250","article-title":"Motor neuron disease in 2014. Biomarkers for ALS\u2014in search of the promised land","volume":"11","author":"Chio","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jmb.2010.04.019","article-title":"Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants","volume":"399","author":"Munch","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cca.2016.01.011_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cca.2016.01.011_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(14)70233-9","article-title":"C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis","volume":"14","author":"Rohrer","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ejhg.2012.98","article-title":"The C9ORF72 expansion mutation is a common cause of ALS+\/\u2212FTD in Europe and has a single founder","volume":"21","author":"Smith","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature14974","article-title":"GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport","volume":"525","author":"Freibaum","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0150","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","volume":"125","author":"Yuan","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cca.2016.01.011_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005072-198801000-00002","article-title":"Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients","volume":"47","author":"Munoz","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ceb.2015.01.003","article-title":"Neurofilament assembly and function during neuronal development","volume":"32","author":"Laser-Azogui","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.cca.2016.01.011_bb0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cca.2016.01.011_bb0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neulet.2012.04.018","article-title":"Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis","volume":"516","author":"Shan","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2016.01.011_bb0175","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0180","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00415-009-0131-z","article-title":"CSF neurofilament protein analysis in the differential diagnosis of ALS","volume":"256","author":"Reijn","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0185","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2016.01.011_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/21678421.2012.729596","article-title":"pNfH is a promising biomarker for ALS","volume":"14","author":"Ganesalingam","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.cca.2016.01.011_bb0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp-2012-303768","article-title":"Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Boylan","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.01.011_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2014-307672","article-title":"Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study","volume":"86","author":"Lu","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.01.011_bb0205","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/21678421.2014.884592","article-title":"Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis","volume":"15","author":"Lehnert","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.cca.2016.01.011_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2015-311387","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients","author":"Steinacker","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.01.011_bb0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cca.2014.09.011","article-title":"Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"438","author":"Goncalves","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.01.011_bb0220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/ene.12390","article-title":"Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis","volume":"21","author":"Sellner","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0225","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/jnnp-2013-306789","article-title":"Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients","volume":"85","author":"Gresle","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.01.011_bb0230","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2016.01.011_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.cca.2016.01.011_bb0240","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1468-1331.2007.01972.x","article-title":"Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype","volume":"14","author":"Zetterberg","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0245","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.01.011_bb0255","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0260","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/jnnp-2013-305494","article-title":"Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis","volume":"85","author":"Puentes","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.01.011_bb0265","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0270","doi-asserted-by":"crossref","unstructured":"R. Tortelli, M. Copetti, M. Ruggieri, R. Cortese, R. Capozzo, A. Leo, E. D'Errico, M. Mastrapasqua, S. Zoccolella, F. Pellegrini, I.L. Simone, G. Logroscino, Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis, Eur. J. Neurol. 22 (2015) 215\u2013218.","DOI":"10.1111\/ene.12421"},{"key":"10.1016\/j.cca.2016.01.011_bb0275","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y","article-title":"Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis","volume":"46","author":"Tohgi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1179\/135100005X70242","article-title":"Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients","volume":"10","author":"Kokic","year":"2005","journal-title":"Redox Rep."},{"key":"10.1016\/j.cca.2016.01.011_bb0290","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/A:1022853531855","article-title":"Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients","volume":"28","author":"Boll","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cca.2016.01.011_bb0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1179\/016164105X18430","article-title":"Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation","volume":"27","author":"Ihara","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cca.2016.01.011_bb0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/17482960801984358","article-title":"Gender difference in levels of Cu\/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"9","author":"Frutiger","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.cca.2016.01.011_bb0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-4159.2011.07177.x","article-title":"Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients","volume":"117","author":"Zetterstrom","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2016.01.011_bb0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cca.2016.01.011_bb0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/17482968.2010.541263","article-title":"Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value","volume":"12","author":"Noto","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.cca.2016.01.011_bb0320","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/00207454.2013.848440","article-title":"Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barre syndrome by quantitative determination of TDP-43 in cerebrospinal fluid","volume":"124","author":"Hosokawa","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.cca.2016.01.011_bb0325","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/21678421.2014.905606","article-title":"Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases","volume":"15","author":"Feneberg","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.cca.2016.01.011_bb0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2007.09.024","article-title":"Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis","volume":"428","author":"Gomes","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2016.01.011_bb0335","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1073\/pnas.1312245111","article-title":"Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms","volume":"111","author":"Grad","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2016.01.011_bb0340","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cca.2016.01.011_bb0345","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jprot.2014.04.028","article-title":"Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset","volume":"106","author":"Chiasserini","year":"2014","journal-title":"J. Proteome"},{"key":"10.1016\/j.cca.2016.01.011_bb0350","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2016.01.011_bb0355","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamaneurol.2013.6064","article-title":"Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis","volume":"71","author":"Grossman","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0360","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neurobiolaging.2014.10.019","article-title":"Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"36","author":"Wilke","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cca.2016.01.011_bb0365","doi-asserted-by":"crossref","first-page":"947513","DOI":"10.1155\/2014\/947513","article-title":"Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis","volume":"2014","author":"Pronto-Laborinho","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2016.01.011_bb0370","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1212\/01.WNL.0000129913.44351.A3","article-title":"Low levels of the vascular endothelial growth factor in CSF from early ALS patients","volume":"62","author":"Devos","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nmd.2006.10.004","article-title":"High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia","volume":"17","author":"Just","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.cca.2016.01.011_bb0380","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/17482968.2011.584881","article-title":"Erythropoietin and amyotrophic lateral sclerosis: plasma level determination","volume":"12","author":"Carilho","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.cca.2016.01.011_bb0385","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/mus.23955","article-title":"Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation","volume":"49","author":"Carilho","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2016.01.011_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087398","article-title":"The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis","volume":"9","author":"Shepheard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.01.011_bb0395","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/01.wnl.0000188907.97339.76","article-title":"Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?","volume":"65","author":"Moreau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0400","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1021\/pr100409r","article-title":"Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach","volume":"9","author":"Zhou","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2016.01.011_bb0405","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1559-0275-10-19","article-title":"Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis","volume":"10","author":"Varghese","year":"2013","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.cca.2016.01.011_bb0410","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.24372","article-title":"Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis","volume":"77","author":"Davoli","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.06.003","article-title":"Serum microRNAs in sporadic amyotrophic lateral sclerosis","volume":"36","author":"Freischmidt","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cca.2016.01.011_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089065","article-title":"MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis","volume":"9","author":"Toivonen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.01.011_bb0425","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","article-title":"Identification of potential CSF biomarkers in ALS","volume":"66","author":"Pasinetti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2009.10.053","article-title":"Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS)","volume":"468","author":"Brettschneider","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2016.01.011_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044401","article-title":"Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic","volume":"7","author":"von Neuhoff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.01.011_bb0440","first-page":"1505","article-title":"Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis","volume":"70","author":"Su","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035772","article-title":"Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells","volume":"7","author":"Edri-Brami","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.01.011_bb0450","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ymgme.2011.11.201","article-title":"ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations","volume":"105","author":"Wuolikainen","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2016.01.011_bb0455","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/17482968.2011.619197","article-title":"Biochemical alterations associated with ALS","volume":"13","author":"Lawton","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.cca.2016.01.011_bb0460","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/21678421.2014.908311","article-title":"Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics","volume":"15","author":"Lawton","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.cca.2016.01.011_bb0465","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-014-7331-x","article-title":"Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis","volume":"261","author":"Abraham","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0470","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/pr400376e","article-title":"Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry","volume":"12","author":"Blasco","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2016.01.011_bb0475","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/21678421.2015.1053490","article-title":"The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis","volume":"16","author":"Gray","year":"2015","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.cca.2016.01.011_bb0480","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065524","article-title":"Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis","volume":"21","author":"Beghi","year":"2002","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.cca.2016.01.011_bb0485","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2014.06.003","article-title":"Delayed diagnosis in ALS: the problem continues","volume":"343","author":"Nzwalo","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2016.01.011_bb0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng1001-166","article-title":"A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2","volume":"29","author":"Hadano","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0495","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/hmg\/ddi440","article-title":"Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2\/alsin exhibit age-dependent neurological deficits and altered endosome trafficking","volume":"15","author":"Hadano","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0500","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/337945","article-title":"A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q","volume":"70","author":"Hand","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0505","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","article-title":"DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)","volume":"74","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0510","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/brain\/awp325","article-title":"SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis","volume":"133","author":"Orlacchio","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.cca.2016.01.011_bb0515","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cca.2016.01.011_bb0520","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cca.2016.01.011_bb0525","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/377158","article-title":"Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis","volume":"73","author":"Sapp","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0530","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0535","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","article-title":"ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis","volume":"38","author":"Greenway","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0540","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0545","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cca.2016.01.011_bb0550","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajhg.2008.12.010","article-title":"Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS","volume":"84","author":"Chow","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature08971","article-title":"Mutations of optineurin in amyotrophic lateral sclerosis","volume":"465","author":"Maruyama","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0560","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0565","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2016.01.011_bb0570","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0575","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ana.22534","article-title":"A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis","volume":"70","author":"Al-Saif","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.01.011_bb0580","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000231510.89311.8b","article-title":"ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)","volume":"67","author":"Parkinson","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.01.011_bb0585","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature11280","article-title":"Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis","volume":"488","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0590","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajhg.2013.09.008","article-title":"ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19","volume":"93","author":"Takahashi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2016.01.011_bb0595","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature11922","article-title":"Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS","volume":"495","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.01.011_bb0600","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.3688","article-title":"Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis","volume":"17","author":"Johnson","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cca.2016.01.011_bb0605","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuron.2014.09.027","article-title":"Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS","volume":"84","author":"Smith","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2016.01.011_bb0610","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.284.13.1664","article-title":"Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21\u2013q22","volume":"284","author":"Hosler","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2016.01.011_bb0615","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"De Jesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2016.01.011_bb0620","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/awu138","article-title":"A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement","volume":"137","author":"Bannwarth","year":"2014","journal-title":"Brain"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116300109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116300109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T14:06:30Z","timestamp":1567519590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898116300109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":124,"alternative-id":["S0009898116300109"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.01.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging molecular biomarker targets for amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}